CSF3 and cancer: Additional strategies include treatment with granulocyte colony stimulating factor (G-CSF) (Saito et al., 2010) or a small molecule checkpoint kinase 1 inhibitor GDC-0575 (Di Tullio et al., 2017) which were successfully used in preclinical studies to drive dormant cancer cells back into a cycling state.